Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer

Cited by (411)

Items 101–200 of 411

  1. Molecular Events in the Natural History of Pancreatic Cancer
    Leslie E. Oldfield, Ashton Anthony Connor, Steve Gallinger · 2017 · Trends in cancer
  2. The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma
    Theodore Evan, Victoria M.-Y. Wang, Axel Behrens · 2022 · Oncogene
  3. Shared cancer neoantigens: Making private matters public
    Christopher Austin Klebanoff, Jedd D. Wolchok · 2017 · The Journal of Experimental Medicine
  4. Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma
    Luís Arnes, Zhaoqi Liu, Jiguang Wang, H. Carlo Maurer, Irina R. Sagalovskiy, Marta Sánchez-Martín, Nikhil K. Bommakanti, Diana C. Garofalo, Dina A. Balderes, Lori Sussel et al. · 2018 · Gut
  5. Single‐cell sequencing defines genetic heterogeneity in pancreatic cancer precursor lesions
    Yuko Kuboki, Catherine G. Fischer, Violeta Beleva Guthrie, Wenjie Huang, Jun Yu, Peter E. Chianchiano, Waki Hosoda, Hao Zhang, Lily Zheng, Xiaoshan M. Shao et al. · 2018 · The Journal of Pathology
  6. Genomic control of metastasis
    Saroor A. Patel, Paulo Rodrigues, Ludovic Wesolowski, Sakari Vanharanta · 2020 · British Journal of Cancer
  7. Intrapancreatic fat, pancreatitis, and pancreatic cancer
    Anna C. Lilly, Igor A. Astsaturov, Erica A. Golemis · 2023 · Cellular and Molecular Life Sciences
  8. Transcriptomic classes of BCR-ABL1 lymphoblastic leukemia
    Jaeseung C. Kim, Michelle Chan‐Seng‐Yue, Sabrina Ge, Andy G.X. Zeng, Karen Ng, Olga I. Gan, Laura García‐Prat, Eugenia Flores Figueroa, Tristan Woo, Amy Xin Wei Zhang et al. · 2023 · Nature Genetics
  9. NF-kappaB-dependent lymphoid enhancer co-option promotes renal carcinoma metastasis
    Paulo Rodrigues, Saroor A. Patel, Louise Harewood, Ioana Olan, E. Vojtasova, S. E. Syafruddin, M. N. Zaini, E. Richardson, Johanna Burge, A. Warren et al. · 2018 · Cancer Discovery
  10. Liquid Biopsy as Surrogate for Tissue for Molecular Profiling in Pancreatic Cancer: A Meta-Analysis Towards Precision Medicine
    Claudio Luchini, Nicola Veronese, Alessia Nottegar, Vera Cappelletti, Maria Grazia Daidone, Lee Smith, Christopher N. Parris, Lodewijk A.A. Brosens, Maria Gabriella Caruso, Liang Cheng C et al. · 2019 · Cancers
  11. Pre-clinical Models of Metastasis in Pancreatic Cancer
    Miquel, Maria, Zhang, Shuman, Pilarsky, Christian · 2021 · Frontiers in Cell and Developmental Biology
  12. New Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis
    Matthäus Felsenstein, Ralph H. Hruban, Laura DeLong Wood · 2017 · Advances in Anatomic Pathology
  13. A genetic roadmap of pancreatic cancer: still evolving
    Faiyaz Notta, Stephan A. Hahn, Francisco X. Real · 2017 · Gut
  14. Induction of DNMT3B by PGE2 and IL6 at Distant Metastatic Sites Promotes Epigenetic Modification and Breast Cancer Colonization
    Jae Young So, Nicolas Skrypek, Howard Hua Yang, Anand S. Merchant, George W. Nelson, Wei-dong D. Chen, Hiroki Ishii, Jennifer M. Chen, Gangqing Hu, Bhagelu R. Achyut et al. · 2020 · Cancer Research
  15. Reviewing cancer’s biology: an eclectic approach
    Ibrahim KARIDIO DIORI, Şenay Hamarat Şanlıer · 2021 · Journal of the Egyptian National Cancer Institute
  16. Epigenetic Alterations in Pancreatic Cancer Metastasis
    Sarah S. Wang, Jihao Xu, Keely Y. Ji, Chang‐Il Hwang · 2021 · Biomolecules
  17. RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing
    Michelle M. Maurin, Mohammadreza Ranjouri, Cristina Megino‐Luque, Justin Y. Newberg, Dongliang Du, Katelyn Martin, Robert E Miner, Mollie S. Prater, Dave Keng Boon Wee, Barbara Ann Centeno et al. · 2023 · Nature Communications
  18. Consecutive seeding and transfer of genetic diversity in metastasis
    Alexander Heyde, Johannes G. Reiter, Kamila Naxerova, Martin A. Nowak · 2019 · Proceedings of the National Academy of Sciences
  19. A set of microRNAs coordinately controls tumorigenesis, invasion, and metastasis
    Iacovos Prodromos Michael, Sadegh Saghafinia, Douglas Hanahan · 2019 · Proceedings of the National Academy of Sciences
  20. HDAC2 Facilitates Pancreatic Cancer Metastasis
    Lukas Krauß, Bettina C. Urban, Sieglinde Hastreiter, Carolin Schneider, Patrick Wenzel, Zonera Hassan, Matthias Wirth, Katharina Lankes, Andrea Terrasi, Christine Klement et al. · 2021 · Cancer Research
  21. Epigenome Remodeling in Cholangiocarcinoma
    Colm J. O’Rourke, Juan F. Lafuente-Barquero, Jesper Bøje Andersen · 2019 · Trends in cancer
  22. Genetic and microenvironmental intra-tumor heterogeneity impacts colorectal cancer evolution and metastatic development
    Daniel Sobral, Marta Martins, Shannon Kaplan, Mahdi Golkaram, Michael Salmans, Nafeesa Khan, Raakhee Vijayaraghavan, Sandra Casimiro, Afonso Fernandes, Paula Borralho et al. · 2022 · Communications Biology
  23. Multifocal Organoid Capturing of Colon Cancer Reveals Pervasive Intratumoral Heterogenous Drug Responses
    Soon‐Chan Kim, Ji Won Park, Ha‐Young Seo, Min Jung Kim, Jae‐Hyeon Park, Ga‐Hye Kim, Ja Oh Lee, Young‐Kyoung Shin, Jeong Mo Bae, Bon‐Kyoung Koo et al. · 2021 · Advanced Science
  24. Delineating the evolutionary dynamics of cancer from theory to reality
    Ivana Božić, Catherine J. Wu · 2020 · Nature Cancer
  25. Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy
    Masahiro Okada, Kanako Shimizu, Shin‐ichiro Fujii · 2022 · International Journal of Molecular Sciences
  26. SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization
    Chao Dai, Jonathan P. Rennhack, Taylor E. Arnoff, Maneesha Thaker, Scott T. Younger, John G. Doench, August Yue Huang, Annan Yang, Andrew J. Aguirre, Belinda Lei Wang et al. · 2021 · Cell Reports
  27. Connecting Metabolic Rewiring With Phenotype Switching in Melanoma
    Paola Falletta, Colin R. Goding, Yurena Vivas · 2022 · Frontiers in Cell and Developmental Biology
  28. Current Status of Immunotherapies for Treating Pancreatic Cancer
    Annie A. Wu, Elizabeth M. Jaffee, Valerie Lee · 2019 · Current Oncology Reports
  29. Multi‐omics analysis of intra‐tumoural and inter‐tumoural heterogeneity in pancreatic ductal adenocarcinoma
    Xiaoqian Liu, Wenqian Wang, Xiaoding Liu, Zhiwen Zhang, Lianyuan Yu, Ruiyu Li, Dan Guo, Weijing Cai, Xueping Quan, Huanwen Wu et al. · 2022 · Clinical and Translational Medicine
  30. Association of the Microbiota and Pancreatic Cancer: Opportunities and Limitations
    Zhou Chen, Shaofeng Zhang, Shi Dong, Hao Ming Xu, Wence Zhou · 2022 · Frontiers in Immunology
  31. KDM6A regulates cell plasticity and pancreatic cancer progression by noncanonical activin pathway
    Yi, Zhujun, Wei, Shanqiao, Jin, Lin, Jeyarajan, Sivakumar, Yang, Jing, Gu, Yumei, Kim, Hong Sun, Schechter, Shula, Lu, Shuang, Paulsen, Michelle T. et al. · 2022 · Cellular and Molecular Gastroenterology and Hepatology
  32. Paracrine and cell autonomous signalling in pancreatic cancer progression and metastasis
    Stacy K. Thomas, Jesse Lee, Gregory Lawrence Beatty · 2020 · EBioMedicine
  33. An Epigenetic Perspective on Intra-Tumour Heterogeneity: Novel Insights and New Challenges from Multiple Fields
    Sven Beyes, Naiara G. Bediaga, Alessio Zippo · 2021 · Cancers
  34. The miR-141/neuropilin-1 axis is associated with the clinicopathology and contributes to the growth and metastasis of pancreatic cancer
    Lixin Ma, Bo Zhai, Huaqiang Zhu, Weidong Li, Wenjing Jiang, Liwang Lei, Shujun Zhang, Haiquan Qiao, Xian Li Jiang, Xueying Sun · 2019 · Cancer Cell International
  35. Establishment of Peritoneal and Hepatic Metastasis Mouse Xenograft Models Using Gastric Cancer Cell Lines
    Takashi Miwa, Mitsuro Kanda, Shinichi Umeda, Haruyoshi Tanaka, Dai Shimizu, Chie Tanaka, Daisuke Kobayashi, Masamichi Hayashi, Suguru Yamada, Goro Nakayama et al. · 2019 · In Vivo
  36. Chemotherapy and Tumor Evolution Shape Pancreatic Cancer Recurrence after Resection
    Filip Bednar, Marina Pasca di Magliano · 2020 · Cancer Discovery
  37. Preclinical models of pancreatic ductal adenocarcinoma: challenges and opportunities in the era of precision medicine
    Yiqi Yu, Gang Yang, Hua Huang, Ziyao Fu, Zhe Cao, Lianfang Zheng, Lei You, Taiping Zhang · 2021 · Journal of Experimental & Clinical Cancer Research
  38. Advances in Molecular Profiling and Categorisation of Pancreatic Adenocarcinoma and the Implications for Therapy
    Rille Pihlak, Jamie M. J. Weaver, Juan W. Valle, Mairead Geraldine McNamara · 2018 · Cancers
  39. CONIPHER: a computational framework for scalable phylogenetic reconstruction with error correction
    Kristiana Grigoriadis, Ariana Huebner, Abigail Bunkum, Emma Colliver, Alexander M. Frankell, Mark S. Hill, Kerstin Thol, Nicolai J. Birkbak, Charles Swanton, Simone Zaccaria et al. · 2023 · Nature Protocols
  40. Cancer tissue of origin constrains the growth and metabolism of metastases
    Sharanya Sivanand, Yetiş Gültekin, Peter S. Winter, Sidney Y. Vermeulen, Konstantine Tchourine, Keene L. Abbott, Laura V. Danai, Florian Gourgue, Brian T. Do, Kayla D. Crowder et al. · 2024 · Nature Metabolism
  41. Pancreatic Cancer Molecular Classifications: From Bulk Genomics to Single Cell Analysis
    Luca Pompella, Giuseppe Tirino, Annalisa Pappalardo, Marianna Caterino, Anna Ventriglia, Valeria Nacca, Michele Orditura, Fortunato Ciardiello, Ferdinando De Vita · 2020 · International Journal of Molecular Sciences
  42. Prognostic stratification of resected pancreatic ductal adenocarcinoma: Past, present, and future
    Aline Barhli, Jerome F. Cros, Laurent Bartholin, Cindy Neuzillet · 2018 · Digestive and Liver Disease
  43. Tracing Tumor Evolution in Sarcoma Reveals Clonal Origin of Advanced Metastasis
    Yuning J. Tang, Jianguo Huang, Hidetoshi Tsushima, Ga I Ban, Hongyuan Zhang, Kristianne Michelle Oristian, Vijitha Puviindran, Nerissa T. Williams, Xiruo Ding, Jianhong Ou et al. · 2019 · Cell Reports
  44. Behind the Wheel of Epithelial Plasticity in KRAS-Driven Cancers
    Emily Nicole Arner, Wenting Du, Rolf A. Brekken · 2019 · Frontiers in Oncology
  45. Molecular dissection of CRC primary tumors and their matched liver metastases reveals critical role of immune microenvironment, EMT and angiogenesis in cancer metastasis
    Jiangang Liu, Yong Beom Cho, Hye Kyung Hong, Song Wu, Philip J. Ebert, Steven M. Bray, Swee Seong Wong, Jason C. Ting, John N. Calley, Catherine F. Whittington et al. · 2020 · Scientific Reports
  46. Mutant p53R270H drives altered metabolism and increased invasion in pancreatic ductal adenocarcinoma
    Heather K. Schofield, Jörg Zeller, Carlos E. Espinoza, Christopher J. Halbrook, Annachiara Del Vecchio, Brian Magnuson, Tania Fabo, Ayse Ece Cali Daylan, Ilya Kovalenko, Ho‐Joon Lee et al. · 2018 · JCI Insight
  47. An epigenetic perspective on tumorigenesis: Loss of cell identity, enhancer switching, and NamiRNA network
    Ying Jie Liang, Peng Xu, Qingping Zou, Huaibing Luo, Wenqiang Yu · 2018 · Seminars in Cancer Biology
  48. Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance
    Shin‐Heng Chiou, Madeleine Dorsch, Eva Kusch, Santiago Naranjo, Margaret M. Kozak, Albert C. Koong, Monte M. Winslow, Barbara M. Grüner · 2018 · Scientific Reports
  49. Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer
    Tracy L. Leong, Velimir Gayevskiy, Daniel Steinfort, Marc Robert de Massy, Álvaro González-Rajal, Kieren D. Marini, Emily C.A. Stone, Venessa T. Chin, Adrian P. Havryk, M. Plit et al. · 2018 · Oncogene
  50. Epigenetic and genetic heterogeneity in metastasis
    Gemma K. Alderton · 2017 · Nature reviews. Cancer
  51. Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?
    Erica S. Tsang, James Thomas Topham, Joanna M. Karasinska, Michael K.C. Lee, Laura Williamson, Shehara Ramyalini Mendis, Robert Edward Denroche, Gun Ho Jang, Steve E. Kalloger, Richard A. Moore et al. · 2020 · Clinical Cancer Research
  52. Pentose conversions support the tumorigenesis of pancreatic cancer distant metastases
    Bechard, Matthew E., Word, Anna E., Tran, Amanda V., Liu, Xiaojing, Locasale, Jason W., McDonald, Oliver G. · 2018 · Oncogene
  53. Pancreatic cancers suppress negative feedback of glucose transport to reprogram chromatin for metastasis
    Bechard, Matthew E., Smalling, Rana, Hayashi, Akimasa, Zhong, Yi, Word, Anna E., Campbell, Sydney L., Tran, Amanda V., Weiss, Vivian L., Iacobuzio-Donahue, Christine, Wellen, Kathryn E. et al. · 2020 · Nature Communications
  54. Enhancer reprogramming in tumor progression: a new route towards cancer cell plasticity
    Luca Fagnocchi, Vittoria Poli, Alessio Zippo · 2018 · Cellular and Molecular Life Sciences
  55. Targeting lipid metabolism in cancer metastasis
    Gloria Pascual, Blanca Majem, Salvador Aznar Benitah · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  56. Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer
    Min Yu, Weifeng Hong, Shiye Ruan, Renguo Guan, Lei Tu, Bowen Huang, Baohua Hou, Zhixiang Jian, Liheng Ma, Haosheng Jin · 2019 · Frontiers in Oncology
  57. Genomic heterogeneity in pancreatic cancer organoids and its stability with culture
    Olalekan H. Usman, Liting Zhang, Gengqiang Xie, Hemant Mahendrakumar Kocher, Chang‐Il Hwang, Yue Julia Wang, Xian Mallory, Jerome Irianto · 2022 · npj Genomic Medicine
  58. Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma
    Ziying Jian, Tao Cheng, Zhiheng Zhang, Susanne Raulefs, Kuangyu Shi, Katja Steiger, Nadja Maeritz, Karin Kleigrewe, Thomas Hofmann, Simone Benitz et al. · 2018 · Cellular and Molecular Gastroenterology and Hepatology
  59. The Cell Biology of Metastatic Invasion in Pancreatic Cancer: Updates and Mechanistic Insights
    Joshi, Vidhu B., Gutierrez Ruiz, Omar L., Razidlo, Gina L. · 2023 · Cancers
  60. The Potent G-Quadruplex-Binding Compound QN-302 Downregulates S100P Gene Expression in Cells and in an In Vivo Model of Pancreatic Cancer
    A. Ahmed, W. Greenhalf, D. Palmer, Nicole Williams, Jane Worthington, Tariq Arshad, S. Haider, E. Alexandrou, D. Guneri, Z. Waller et al. · 2023 · Molecules
  61. Mesenchymal–epithelial transition of pancreatic cancer cells at perineural invasion sites is induced by Schwann cells
    Yoko Fujii‐Nishimura, Ken Yamazaki, Yohei Masugi, Junya Douguchi, Yutaka Kurebayashi, Naoto Kubota, Hidenori Ojima, Minoru Kitago, Masahiro Shinoda, Akinori Hashiguchi et al. · 2018 · Pathology International
  62. Integrated analysis of somatic mutations and immune microenvironment of multiple regions in breast cancers
    Taigo Kato, Jae-Hyun Park, Kazuma Kiyotani, Yuji Ikeda, Yasuo Miyoshi, Yusuke Nakamura · 2017 · Oncotarget
  63. An epigenetic perspective on tumorigenesis: Loss of cell identity, enhancer switching, and NamiRNA network
    Ying Jie Liang, Peng Xu, Qingping Zou, Huaibing Luo, Wenqiang Yu · 2018 · Seminars in Cancer Biology
  64. Mutated EPHA2 is a target for combating lymphatic metastasis in intrahepatic cholangiocarcinoma
    Yuan‐Yuan Sheng, Jinwang Wei, Yu Zhang, Xiaomei Gao, Zheng Wang, Jing Yang, Shican Yan, Ying Zhu, Ze Zhang, Da Xu et al. · 2018 · International Journal of Cancer
  65. Multi-omic molecular comparison of primary versus metastatic pancreatic tumours
    Gagandeep Singh Brar, Edik Matthew Blais, R Joseph Bender, Jonathan Robert Brody, Davendra P. S. Sohal, Subha Madhavan, Vincent J. Picozzi, Andrew Eugene Hendifar, Vincent M. Chung, David Halverson et al. · 2019 · British Journal of Cancer
  66. Inhibition of Mitochondrial ATP Synthesis and Regulation of Oxidative Stress Based on {SbW8O30} Determined by Single‐Cell Proteomics Analysis
    Lige Gong, Wenqiao Ding, Ying Chen, Kai Yu, Changhong Guo, Baibin Zhou · 2021 · Angewandte Chemie International Edition
  67. Genomic characteristics of invasive mucinous adenocarcinoma of the lung with multiple pulmonary sites of involvement
    Moonsik Kim, Jinha Hwang, Kyunga Kim, Sohyun Hwang, Hye‐Jeong Lee, Ji Ye Jung, Jin Gu Lee, Yoon Jin Cha, Hyo Sup Shim · 2021 · Modern Pathology
  68. An epigenetic signature of advanced colorectal cancer metastasis
    Euan James Rodger, Grégory Gimenez, Priyadarshana Ajithkumar, Peter A. Stockwell, Suzan N. Almomani, Sarah A. Bowden, Anna L. Leichter, Antonio Ahn, Sharon Tracy Pattison, John L McCall et al. · 2023 · iScience
  69. Epigenetic regulation of breast cancer metastasis
    Chitra Thakur, Yiran Qiu, Aashna S. Pawar, Fei Chen · 2023 · Cancer and Metastasis Reviews
  70. Advances in Targeted Therapy and Immunotherapy for Pancreatic Cancer
    Xiaoxiao Liu, Zhang Li, Yuexiang Wang · 2021 · Advanced Biology
  71. Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1
    Yan Han, Chih-Chieh Yu, Stuart A. Fine, Ayman Lee Youssof, Yeran Yang, Jun Yan, Dillon C. Karg, Edwin C. Cheung, Richard A. Friedman, Haoqiang Ying et al. · 2021 · Oncogene
  72. Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary
    Claudio Luchini, Antonio Pea, Jun Yu, Jin Peng He, Roberto Salvia, Giulio Riva, Matthew John Weiss, Claudio Bassi, John L. Cameron, Ralph H. Hruban et al. · 2018 · Modern Pathology
  73. Neoantigen-based immunotherapy in pancreatic ductal adenocarcinoma (PDAC)
    Hao Chen, Gang Yang, Jianchun Xiao, Lianfang Zheng, Lei You, Taiping Zhang · 2020 · Cancer Letters
  74. ParsVNN: parsimony visible neural networks for uncovering cancer-specific and drug-sensitive genes and pathways
    Xiaoqing Huang, Kun Huang, Travis S. Johnson, Milan Radovich, Jie Zhang, Jianzhu Ma, Yijie Wang · 2021 · NAR Genomics and Bioinformatics
  75. Proteome Profiling of Primary Pancreatic Ductal Adenocarcinomas Undergoing Additive Chemoradiation Link ALDH1A1 to Early Local Recurrence and Chemoradiation Resistance
    Victor Oginga Oria, Peter Bronsert, Andreas R. Thomsen, Melanie Christine Föll, C. Zamboglou, Luciana Hannibal, Simon P. Behringer, Martin Lothar Biniossek, Cleopatra Schreiber, Anca‐Ligia Grosu et al. · 2018 · Translational Oncology
  76. The Evolutionary Forest of Pancreatic Cancer
    Katelyn M. Mullen, Jungeui Hong, Marc A. Attiyeh, Akimasa Hayashi, Hitomi Sakamoto, Zachary A. Kohutek, Caitlin A. McIntyre, Haochen Zhang, Alvin P. Makohon-Moore, Amanda Zucker et al. · 2024 · Cancer Discovery
  77. Metastatic heterogeneity in pancreatic cancer: mechanisms and opportunities for targeted intervention
    Ravikanth Maddipati · 2025 · Journal of Clinical Investigation
  78. Deregulation of Transcription Factor Networks Driving Cell Plasticity and Metastasis in Pancreatic Cancer
    Ruthger van Roey, Thomas Brabletz, Marc P. Stemmler, Isabell Armstark · 2021 · Frontiers in Cell and Developmental Biology
  79. Genetic Landscape of Multistep Hepatocarcinogenesis
    H. Takeda, Atsushi Takai, Yuji Eso, Ken Takahashi, H. Marusawa, H. Seno · 2022 · Cancers
  80. Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
    Qianying Zuo, Ayca Nazli Mogol, Yu-Jeh Liu, Ashlie Santaliz Casiano, Christine Chien, Jenny M. Drnevich, Ozan Berk Imir, Eylem Kulkoyluoglu‐Cotul, Nicole Hwajin Park, David J. Shapiro et al. · 2022 · Molecular Cancer Research
  81. Targeting Driver Oncogenes and Other Public Neoantigens Using T Cell Receptor–Based Cellular Therapy
    Tijana Martinov, Philip D. Greenberg · 2023 · Annual Review of Cancer Biology
  82. Whole-Exome Sequencing Among Chinese Patients With Hereditary Diffuse Gastric Cancer
    Zexian Liu, Xiaolong Zhang, Qi Zhao, Yungchang Chen, Hui Sheng, Caiyun He, Yuting Sun, Ming-Yu Lai, Minqing Wu, Zhixiang Zuo et al. · 2022 · JAMA Network Open
  83. THBS2/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement
    Shirsa Udgata, Naomi Takenaka, William R. Bamlet, Ann L. Oberg, Stephanie S. Yee, Erica L. Carpenter, Daniel S. Herman, Jungsun Kim, Gloria M. Petersen, Kenneth S. Zaret · 2020 · Cancer Prevention Research
  84. Multi-omic analysis of gallbladder cancer identifies distinct tumor microenvironments associated with disease progression
    Tao Zhou, Yanhong Wu, Shuai Li, Xinyao Qiu, Erdong Liu, Zhihua Xie, Xuebing Shi, Yani Zhang, Guosheng Ma, Wenbo Guo et al. · 2025 · Nature Genetics
  85. Advances in the Genetics and Biology of Pancreatic Cancer
    Andrew J. Aguirre, Eric Andrew Collisson · 2017 · The Cancer Journal
  86. Emerging evidence of the molecular landscape specific for hematogenous metastasis from gastric cancer
    Dai Shimizu, Mitsuro Kanda, Yasuhiro Kodera · 2018 · World Journal of Gastrointestinal Oncology
  87. Genome‐wide profiling of circulating tumor DNA depicts landscape of copy number alterations in pancreatic cancer with liver metastasis
    Tao Wei, Jian Zhang, Jin Li, Qi Chen, Xiao Zhi, Tao Wei, Jingjiao Ma, Jiaqi Yang, Yu Lou, Tao Ma et al. · 2020 · Molecular Oncology
  88. Tumor Evolution, Heterogeneity, and Therapy for Our Patients With Advanced Cancer: How Far Have We Come?
    Wafik S. El‐Deiry, Barry S. Taylor, Joel W. Neal · 2017 · American Society of Clinical Oncology Educational Book
  89. Drivers of Gene Expression Dysregulation in Pancreatic Cancer
    Swati Venkat, Abdulrahman A. Alahmari, Michael E. Feigin · 2021 · Trends in cancer
  90. Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment
    Asmaa Elrakaybi, Dietrich Alexander Ruess, Michael Lübbert, Michael Quante, Heiko Becker · 2022 · Cancers
  91. Circulating Tumor DNA Methylation Biomarkers for Characterization and Determination of the Cancer Origin in Malignant Liver Tumors
    Tina Draškovič, Nina Zidar, Nina Hauptman · 2023 · Cancers
  92. From Chemotherapy to Combined Targeted Therapeutics: In Vitro and in Vivo Models to Decipher Intra-tumor Heterogeneity
    Guido Gambara, Manuela Gaebler, Ulrich Keilholz, Christian R. A. Regenbrecht, Alessandra Silvestri · 2018 · Frontiers in Pharmacology
  93. A New Strategy to Control and Eradicate “Undruggable” Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary Biology
    Robert E. Van Sciver, Michael Lee, Caroline Guat Lay Lee, Alex Lafever, Elizaveta A. Svyatova, Kevin Kanda, Amber L. Collier, Lauren L. Siewertsz van Reesema, Angela M. Tang-Tan, Vasilena P. Zheleva et al. · 2018 · Cancers
  94. Phenotypic heterogeneity and tumor immune microenvironment directed therapeutic strategies in pancreatic ductal adenocarcinoma
    Remya P. G. Ramesh, Hadida Yasmin, Pretty Ponnachan, Basel K. al-Ramadi, Uday Kishore, Ann Mary Joseph · 2025 · Frontiers in Immunology
  95. Epigenetic control of pancreatic cancer metastasis
    Lukas Krauß, Carolin Schneider, Elisabeth Heßmann, Dieter Saur, Günter Schneider · 2023 · Cancer and Metastasis Reviews
  96. Application of single-cell sequencing technologies in pancreatic cancer
    Mastan Mannarapu, Begum Dariya, Obul Reddy Bandapalli · 2021 · Molecular and Cellular Biochemistry
  97. State of the Art: Toward Improving Outcomes of Lung and Liver Tumor Biopsies in Clinical Trials—A Multidisciplinary Approach
    Elliot B. Levy, Maria Isabel Fiel, Stanley R. Hamilton, David Erwin Kleiner, Shannon J. McCall, Peter Schirmacher, William David Travis, Michael D. Kuo, Robert D. Suh, Alda Lui Tam et al. · 2020 · Journal of Clinical Oncology
  98. Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma
    Daniel Oyón, Amaya López-Pascual, Borja Castelló-Uribe, Iker Uriarte, Giulia Orsi, Sofia Llorente, Jasmin Elurbide, Elena Adán-Villaescusa, Emiliana Valbuena-Goiricelaya, Ainara Irigaray-Miramon et al. · 2025 · Journal of Experimental & Clinical Cancer Research
  99. Evolutionary paths towards metastasis
    Kamila Naxerova · 2025 · Nature reviews. Cancer
  100. Metastatic tumor cells – genotypes and phenotypes
    Dingcheng Gao, Vivek Mittal, Yi Ban, Ana Rita Lourenço, Shira Yomtoubian, Sharrell B. Lee · 2018 · Frontiers in Biology